We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
OmniAb Inc offers best-in-class therapeutic antibody discovery technologies. OmniAb Inc offers best-in-class therapeutic antibody discovery technologies.
Ask ADVFN Intelligence (AI)
| Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.229 | -6.83786204837 | 3.349 | 3.46 | 3.12 | 327790 | 3.35573819 | CS |
| 4 | -0.39 | -11.1111111111 | 3.51 | 4.02 | 3.12 | 561951 | 3.55954445 | CS |
| 12 | -0.695 | -18.2175622543 | 3.815 | 4.02 | 3.1002 | 538358 | 3.47679165 | CS |
| 26 | -1.15 | -26.9320843091 | 4.27 | 4.84 | 3.1002 | 462617 | 3.78861295 | CS |
| 52 | -2.37 | -43.1693989071 | 5.49 | 5.72 | 3.1002 | 521469 | 4.18281259 | CS |
| 156 | -1.95 | -38.4615384615 | 5.07 | 6.715 | 1.91 | 659003 | 4.08410658 | CS |
| 260 | -1.95 | -38.4615384615 | 5.07 | 6.715 | 1.91 | 659003 | 4.08410658 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
